Ledger.Open graph →
SEC Form D · filed January 17, 2014

Blueprint Medicines Corp

Offering
$25.1M
Sold
$23.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David S. Schenkein · Cambridge, MADirectorChristoph S. Lengauer · Cambridge, MAExecChristine W. Bellon · Cambridge, MAExecAlexis S. Borisy · Cambridge, MAExec · DirectorThilo S. Schroeder · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorKyle W. Kuvalanka · Cambridge, MAExecStephen S. Knight · Cambridge, MADirectorNick S. Lydon · Cambridge, MADirectorJesse Brunner · Santa Monica, CAExec · DirectorSteve Adler · Santa Monica, CADirectorMaurice Singer · Santa Monica, CADirectorHarshvardhan P. Sharangpani · Los Altos Hills, CADirectorAlan N. Solon · Atlanta, GAExecRobert M. Mccullough · Atlanta, GAExecClive R. Slovin · Atlanta, GAExecDavid S. Schenkein · Cambridge, MADirectorNick S. Lydon · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗